Globalisation

Sanofi to spin-out and launch European API manufacturer

25-Feb-2020 By Ben Hargreaves

According to the French company, the spinout would enter the market as the second largest API producer globally.

‘You get what you pay for’ on API quality

19-Feb-2020 By Ben Hargreaves

As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.

Sun Pharma blames 'speculative buying' on coronavirus-related price hikes

17-Feb-2020 By Nick Taylor

Sun Pharma argues rising ingredient and finished product prices are unjustified, blames ‘speculative buying’ for trend.

Industry demands ‘closest possible relationship’ between UK and EU

13-Feb-2020 By Ben Hargreaves

European industry organizations call for trade negotiations between the UK and the EU to begin with a mutual recognition agreement.

Cardinal tips API supply chain to weather impact of coronavirus

10-Feb-2020 By Nick Taylor

Cardinal predicts API industry ‘should be able to work through’ coronavirus outbreak despite exposure to China.

Pfizer's CDMO unit drives growth at hospital business

03-Feb-2020 By Nick Taylor

Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.

AZ and Takeda outline sustainability plans

30-Jan-2020 By Ben Hargreaves

Both major pharma companies have used January to announce programs to reduce their climate impact.

Could the coronavirus impact supply of APIs?

29-Jan-2020 By Ben Hargreaves

First quarter supplies of APIs are expected to be affected by the recent outbreak of coronavirus, according to survey.

Pharming plant gets EMA approval, easing Ruconest supply pressures

27-Jan-2020 By Nick Taylor

Pharming receives European approval for manufacturing plant, significantly expanding capacity.

LOMÉ INITIATIVE SIGNING

Demanding quality: WHO on securing a vulnerable supply chain

23-Jan-2020 By Vassia Barba

As African countries look to secure their supply chains, head of the WHO’s team on fighting falsified and substandard medicine speaks about how to ‘demand quality’.

Kyowa Kirin creates quality unit with direct line to CEO

05-Dec-2019 By Nick Taylor

Kyowa Kirin reorganizes to create quality division that reports directly to CEO Masashi Miyamoto.

Pharma Integrates

Lack of collaboration the biggest challenge in adopting blockchain, says IBM

21-Nov-2019 By Vassia Barba

Blockchain technology should be deployed where there are ‘trust issues’ among the different sectors of the industry, executives say.

EMA enters ‘last step’ of relocation process

21-Nov-2019 By Ben Hargreaves

A lease agreement has been signed for the EMA to move into tailor-made premises in Amsterdam, with staff set to begin working from the space in January.

FT Pharmaceutical & Biotechnology Conference

Ipsen on the ‘biotech mindset’ and how to ‘focus on the why’

20-Nov-2019 By Vassia Barba

Speaking at the FT Pharmaceutical & Biotechnology conference earlier this week, Ipsen’s CCO said that pharma manufacturers need to focus more on the ‘why’.